The consortium is formed by hDMT researchers and it is envisaged that the OoC models with integrated lymphatics can be applied as a precision tool in the battle against immune-related diseases.

LymphChip consortium

Human disease and regenerative medicine models, including formats referred to as “organ-on-chip” (OoC), are increasingly regarded as powerful tools for drug discovery, safety pharmacology and efficacy testing, in both personalized and precision medicine. Developed over the past 10 years, they constitute an important new approach to medicine and towards the replacement of animal models. To date, however, OoC models lack the lymphatic and immune system, despite their essential role in health and disease.


We are pleased to announce that the LymphChip project has now officially started.


Academic partners

  • Logo Amsterdam UMC
  • Logo WUR
  • Logo TU Delft
  • Logo Maastricht University
  • Logo LUMC
  • Logo University of Twente

LymphChip Co-Financing Partners

  • logo Tissue GMBH
  • logo Proefdiervrij
  • logo Polyvation
  • Logo One Planet
  • Logo Nostics
  • Logo Ibidi
  • Logo IBA
  • Logo Nederlandse Brandwondenstichting
  • Logo Cealus Health
  • Logo HDMT
  • Logo Optics 11
  • Logo AIM Biotech
  • logo BioEC

Cooperating Partners

  • Logo RIVM
  • Logo Danone Nutricia
  • Logo MLDS
  • logo AMC
  • logo The University of Melbourne
  • logo Ncardia
  • logo Utrecht University
  • Logo WUR

© All rights reserved


Project Manager:

Margot Beukers
Science Business Support 

Project management for life sciences research projects including training and advice

NWO-logo huisstijlsite

The LymphChip consortium is funded by the NWA-ORC programme of the Dutch Research Council
(NWO; project number 1292.19.019)